Skip to main content

Table 1 Age of the patients, tumor size and karyotype of the leiomyomas investigated.

From: Fibroid explants reveal a higher sensitivity against MDM2-inhibitor nutlin-3 than matching myometrium

case no.

Age

tumor-size [cm]

karyotype

0501-1

48

8.0

46, XX [36]

0503-1

40

4.0

46, XX, inv(5)(q15q31~33), t(12;14)(q15;q24)[13]

0504-1

43

2.0

46, XX [11]

0515-1

46

3.0

n.d.

0529-1

44

7.0

46, XX [12]

0529-2

44

5.0

46, XX [14]

0533-1

41

6.0

46, XX, r(1), t(1;12;14)(p36.3;q14;q24)[19]

0535-1

43

5.0

47, XX, +10 [2]/46, XX [10]

0535-2

43

4.0

46, XX, t(8;11)(p23;q13.1)[6]/47, XX, +12 [2]/46, XX [15]

0535-3

43

3.0

46, XX [7]

0535-4

43

2.0

46, XX [15]

0535-5

43

2.0

46, XX, del(7)(q11.2?)[2]/46, XX [12]

0538-4

36

3.0

46, XX [6]

0540-1

49

4.0

46, XX [10]

0540-2

49

N/A

46, XX [4]

0541-1

37

7.0

46, XX, t(12;14)(q15;q24)[5]/46, XX [9]

0545-1

47

5.0

46, XX, t(12;14)(q15;q24)[9]/46, XX [3]

0549-2

49

3.5

46, XX [10]

0549-3

49

4.0

46, XX [10]

0549-4

49

6.0

48, XX, +der(6), -8, +11, +mar [11]

0556-1

42

5.0

46, XX, t(3;5;12)(q25;p14;q15)[11]/45, XX, t(3;5;12)(q25;p14;q15), -22 [10]

0557-1

38

1.0

46, XX [10]

0561-1

44

15.0

n.d.

0579-1

49

1.5

46, XX, t(12;15;14)(q15;q26;q24)[20]

0583-1

40

5.5

46, XX [16]

0596-1

49

8.5

46, XX, ins(2;12)(q34 or q35;q24.3 or q24.1q13), inv(4)(q27q31.3)[22]

0628-1

57

4.0

46, XX, t(2;4)(q33;q25)[14]

0628-2

57

1.5

46, XX, ?ins(12;14)(q15;q31q24)[5]/46, XX [14]

0632-1

47

4.0

46, XX, t(12;14)(q15;q24)[12]/46, XX, del(4)(q31orq32), der(10), ?t(10;14)(q24;q32), t(12;14)(q15;q24)[9]

0635-1

48

N/A

46, XX, der (10), del(12)(q13 or q14) [18]

0643-1

52

1.0

n.d.

0643-2

52

6.0

46, XX, t(12;14)(q15;q24)[14]

0643-3

52

2.0

46, XX [12]

0646-1

47

9.5

46, XX, t(2;12)(p21;p13)[11]

0649-1

42

2.0

46, XX [14] remark: 46, XX, der(14)t(12;14) as single cell aberration

0653-1

50

1.0

46, XX [14]

0653-2

50

1.5

46, XX [15]

0653-3

50

2.5

46, XX [10]

0654-1

43

3.0

46, XX [8]

0654-2

43

2.3

47, XX, +12 [4]/46, XX [12]

0654-3

43

1.8

46, XX [14]

0668-1

57

3.0

46, XX [10]

0668-2

57

2.0

46, XX [11]

0668-3

57

2.5

46, XX [7]

0673-2

45

3.0

46, XX [13]

0681-1

48

7.5

45, XX, der(1)( ?)t(1;14)(p36.3;q24), der(1)del(1)(q32)?t(1;11)(p36.1;q13), del(3)(q26), add(6)(p21.3), -10, -11, del(12)(q24.1), der(14)t(6;14)(p21.3;q24), add(19)(q13.4), +r [20]

0682-1

69

1.5

46, XX [16]

0682-2

69

1.0

46, XX [38]

0683-1

47

6.0

46, XX, del(7)(q22q32)[5]/46, XX [3]

0683-2

47

1.0

46, XX [21]

0686-1

57

6.0

n.d.

0686-2

57

1.0

46, XX [20]

0686-3

57

1.0

46, XX [13]

0687-1

N/A

1.0

46, XX, der(10)add(10)(p)add(10)(q)[3]/46, XX [15]

0694-2

N/A

9.0

n.d.

0695-1

0695-2

0695-3

68

68

68

2.5

6.0

1.0

n.d.

n.d.

n.d.

0700-1

N/A

1.5

46, XX [11]

  1. Karyotypes are described according to [20].